Anbio Biotechnology
NNNN$730M
Small CapNASDAQIn Vitro & In Vivo Diagnostic Substances🇺🇸North AmericaFRANKFURT AM MAIN27 employees
Drugs in Pipeline
0
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
Jul 7, 2026
17dMarket Overview
Stock performance and key metrics
NNNN News
Catalyst Timeline
1 upcoming, 0 past
Drug Pipeline
No drugs found in this phase.
Catalyst Verdict
Market-Implied Move
Regulatory Approvals
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply